US › Healthcare

Heartbeam Inc (BEAT)

US · Healthcare · Health Information Services

$0.44+0.93%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-5.0M

EPS

$-0.10

EPS estimate

$-0.10

EPS came in at -0.10 against a street estimate of -0.10 — a beat of 0.0%.

Key statistics

Market cap

$23.9M

Forward P/E

0.0

P/B

78.02

Book value

$0.14

EPS (TTM)

$-0.50

52-week high

$4.00

52-week low

$0.35

50-day MA

$0.47

200-day MA

$1.01

Beta

-0.77

Analyst view

Analysts rate Heartbeam Inc a buy (2 buy, 1 hold, 0 sell out of 3) with an average price target of $3.50.

Shareholding

Insiders

19.57%

Institutions

14.41%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	3.79%
BlackRock Inc	1.75%
Corsair Capital Management LLC	1.62%
Bleichroeder LP	1.11%
Geode Capital Management, LLC	0.85%
Smith, Salley & Associates, LLC	0.65%
UBS Group AG	0.53%
Vanguard Fiduciary Trust Co	0.49%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Heartbeam Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.